Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD28
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
lulizumab pegol
(BMS-931699) / BMS
theralizumab
(TAB08) / TheraMab
FR104
/ OSE Immunotherapeutics, Asahi Kasei
acazicolcept
(ALPN-101) / AbbVie
nezastomig
(REGN5678) / Regeneron
REGN7075
/ Regeneron
REGN5668
/ Regeneron